Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma

Table 2 Relationship between cancer susceptibility candidate 9 and pathological data

Factors		Patient group (n = 80)	T	P value
Gender			0.308	0.759
	Male (n = 50)	3.287 ± 0.553
	Female (n = 30)	3.326 ± 0.553
Age (yr)			0751	0.455
	< 55 (n = 35)	3.354 ± 0.504
	≥ 55 (n = 45)	3.261 ± 0.585
Tumor size			4.357	< 0.001
	≥ 5 cm (n = 45)	3.489 ± 0.414
	< 5 cm (n = 35)	3.06 ± 0.611
Combined hepatitis			0.575	0.567
	Yes (n = 70)	3.315 ± 0.540
	No (n = 10)	3.208 ± 0.634
TNM stage			4.157	< 0.001
	Stage I+II (n = 33)	3.496 ± 0.448
	Stage III+IV (n = 47)	3.024 ± 0.567
Lymph node metastasis			4.557	< 0.001
	Yes (n = 42)	3.54 ± 0.445
	No (n = 38)	3.038 ± 0.538
Differentiation			4.387	< 0.001
	Low differentiation (n = 27)	3.642 ± 0.405
	Moderate + high differentiation (n = 53)	3.128 ± 0.535
AFP (ng/mL)			3.617	0.001
	≤ 200 (n = 25)	3.609 ± 0.393
	> 200 (n = 55)	3.162 ± 0.557

AFP: Alpha fetoprotein; TNM: Tumor, node, metastasis.